Chinese Network of Pediatric Antiretroviral Therapy

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

Up to 15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention

Beijing, 102206, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

clinical diagnosis of HIV infection
receiving triple antiretroviral drugs

Exclusion criteria

clinical status not stable

Treatment and study plan

Primary outcomes

The immunology and virologic outcomes

Time frame: 2016

Sponsors and collaborators

Lead sponsor

National Center for AIDS/STD Control and Prevention, China CDC

Other Gov

Registry information

Official study title

Chinese Study of Pediatric Antiretroviral Therapy

Acronym: CN-PART

Important dates

Study start: 2010
Primary completion: 2015
Study completion: 2015
First posted: Sep 29, 2010
Registry last updated: Mar 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed